114 related articles for article (PubMed ID: 21726049)
1. A proteomic view of mycobacteria.
de Souza GA; Wiker HG
Proteomics; 2011 Aug; 11(15):3118-27. PubMed ID: 21726049
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the Mycobacterium tuberculosis proteome by liquid chromatography mass spectrometry-based proteomics techniques: a comprehensive resource for tuberculosis research.
Bell C; Smith GT; Sweredoski MJ; Hess S
J Proteome Res; 2012 Jan; 11(1):119-30. PubMed ID: 22053987
[TBL] [Abstract][Full Text] [Related]
4. [Future prospects of molecular epidemiology in tuberculosis].
Matsumoto T; Iwamoto T
Kekkaku; 2009 Dec; 84(12):783-4. PubMed ID: 20077862
[TBL] [Abstract][Full Text] [Related]
5. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
6. Prospective on Mycobacterium tuberculosis proteomics.
Mehaffy MC; Kruh-Garcia NA; Dobos KM
J Proteome Res; 2012 Jan; 11(1):17-25. PubMed ID: 21988637
[TBL] [Abstract][Full Text] [Related]
7. Mycobacterial proteomics: analysis of expressed proteomes and post-translational modifications to identify candidate virulence factors.
Calder B; Soares NC; de Kock E; Blackburn JM
Expert Rev Proteomics; 2015 Feb; 12(1):21-35. PubMed ID: 25603863
[TBL] [Abstract][Full Text] [Related]
8. Mycobacterium tuberculosis in the Proteomics Era.
Gengenbacher M; Mouritsen J; Schubert OT; Aebersold R; Kaufmann SHE
Microbiol Spectr; 2014 Apr; 2(2):. PubMed ID: 26105825
[TBL] [Abstract][Full Text] [Related]
9. Host-pathogen interactions: a proteomic view.
Zhang CG; Chromy BA; McCutchen-Maloney SL
Expert Rev Proteomics; 2005 Apr; 2(2):187-202. PubMed ID: 15892564
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of the proteomes of isoniazid-resistant Mycobacterium tuberculosis strains and isoniazid-susceptible strains].
Jiang X; Gao F; Zhang WH; Hu ZY; Wang HH
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):427-31. PubMed ID: 17673015
[TBL] [Abstract][Full Text] [Related]
11. What Can Proteomics Tell Us about Tuberculosis?
Flores-Villalva S; Rogríguez-Hernández E; Rubio-Venegas Y; Cantó-Alarcón JG; Milián-Suazo F
J Microbiol Biotechnol; 2015 Aug; 25(8):1181-94. PubMed ID: 25737117
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the protective efficacy of bacille calmette-Guérin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis.
Williams A; Davies A; Marsh PD; Chambers MA; Hewinson RG
Clin Infect Dis; 2000 Jun; 30 Suppl 3():S299-301. PubMed ID: 10875804
[TBL] [Abstract][Full Text] [Related]
13. PhoP, a key player in Mycobacterium tuberculosis virulence.
Ryndak M; Wang S; Smith I
Trends Microbiol; 2008 Nov; 16(11):528-34. PubMed ID: 18835713
[TBL] [Abstract][Full Text] [Related]
14. 'Proteomic contigs' of Mycobacterium tuberculosis and Mycobacterium bovis (BCG) using novel immobilised pH gradients.
Urquhart BL; Atsalos TE; Roach D; Basseal DJ; Bjellqvist B; Britton WL; Humphery-Smith I
Electrophoresis; 1997 Aug; 18(8):1384-92. PubMed ID: 9298652
[TBL] [Abstract][Full Text] [Related]
15. Comparison of predicted and observed properties of proteins encoded in the genome of Mycobacterium tuberculosis H37Rv.
Urquhart BL; Cordwell SJ; Humphery-Smith I
Biochem Biophys Res Commun; 1998 Dec; 253(1):70-9. PubMed ID: 9875222
[TBL] [Abstract][Full Text] [Related]
16. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
17. Discrimination of intact mycobacteria at the strain level: a combined MALDI-TOF MS and biostatistical analysis.
Hettick JM; Kashon ML; Slaven JE; Ma Y; Simpson JP; Siegel PD; Mazurek GN; Weissman DN
Proteomics; 2006 Dec; 6(24):6416-25. PubMed ID: 17109381
[TBL] [Abstract][Full Text] [Related]
18. New drug targets for Mycobacterium tuberculosis.
Chopra P; Meena LS; Singh Y
Indian J Med Res; 2003 Jan; 117():1-9. PubMed ID: 12866819
[TBL] [Abstract][Full Text] [Related]
19. Proteome analysis of host-pathogen interactions: Investigation of pathogen responses to the host cell environment.
Schmidt F; Völker U
Proteomics; 2011 Aug; 11(15):3203-11. PubMed ID: 21710565
[TBL] [Abstract][Full Text] [Related]
20. Cell-wall alterations as an attribute of Mycobacterium tuberculosis in latent infection.
Seiler P; Ulrichs T; Bandermann S; Pradl L; Jörg S; Krenn V; Morawietz L; Kaufmann SH; Aichele P
J Infect Dis; 2003 Nov; 188(9):1326-31. PubMed ID: 14593589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
